ArticleESMO open2024

Germline BRCA pathogenic variants in patients with ovarian cancer and post-poly (ADP-ribose) polymerase inhibitor myeloid neoplasms.

C Valenza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.